Flores-Pérez A, Gayosso-Vázquez C, Alcántar-Curiel MD, Arzate-Barbosa P, Alpuche-Aranda C, Arredondo-García JL

Language: English
References: 35
Page: 383-388
PDF size: 414.02 Kb.

ABSTRACT

Introduction: Enteric bacteria causing nosocomial infections are often resistant to third-generation cephalosporins due to the production of extended-spectrum β-lactamases (ESBLs).
Objective: To describe and characterize the ESBLs pattern present in Klebsiella pneumoniae and Serratia marcescens strains, isolated as causative of nosocomial sepsis in pediatric patients at Instituto Nacional de Pediatría (National Institute of Pediatrics).
Material and methods: We analyzed 94 strains of K. pneumoniae and 7 of S. marcescens isolated from clinical specimens from 2002-2005, causative of sepsis in a children’s hospital. We evaluated antibiotic susceptibility and detection of ESBL phenotypes by disk diffusion methods; ceftazidime-resistant isolates were further characterized by pulsed field gel electrophoresis (PFGE); and ESBLs were phenotypically and genotypically characterized by isoelectric focusing, polymerase chain reaction (PCR) and sequencing. We also assed for presence of conjugative plasmids bearing the ESBL gene.
Results: 51/94 (54%) of K. pneumoniae isolates, and 5/7 (71%) of S. marcescens isolates were resistant to ceftazidime; all carried a bla_SHV-5 gene. All K. pneumoniae isolates had a distinct PFGE profile, yet all carried a ~48-Kb plasmid, that was conjugatively transferable to an Escherichia coli receptor, which expressed the resistance phenotype. On the other hand, all S. marcescens isolates had a similar PFGE profile, were unable to transfer the ceftazidime-resistance phenotype, and were isolated from the same ward in a short time-span suggesting an outbreak.
Conclusions: The overall prevalence of ESBL-producing enteric bacteria in this hospital is high but similar to other Latin American reports. The sulfhydryl variable-5 (SHV-5) ESBL gene appears to reside in a highly mobile plasmid, capable of spreading among different K. pneumoniae clones and perhaps even to S. marcescens.

REFERENCES

1. Anthony M, Bedford A, Cooper T, Fry C, Health P, Kennea N, McCartney M, Patel B, Pollard T, Sharland M, Wilson P Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Arch Dis Child Fetal Neonatal Ed 2013;98:F549-F553.

2. Šiširak M, Hukić M An outbreak of multidrug-resistant Serratia marcescens: the importance of continuous monitoring of nosocomial infections. Acta Med Acad 2013;42:25-31.

3. Webster D, Young BC, Morton R, Collyer D, Batchelor B, Turton JF, Maharjan S, Livermore DM, Bejon P, Cookson BD, Boler IC Impact of a clonal outbreak of extendedspectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK. J Antimicrob Chemother 2011;66:2126-2135.

4. Dessi A, Puddu M, Testa M, Marcialis MA, Pintus MC, Fanos V Serratia marcescens infections and outbreaks in neonatal intensive care units. J Chemother 2009;21:493-499.

5. Bush K, Jacoby GA Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 2010;54:969-976.

6. Bush K, Jacoby GA, Medeiros AA A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-1233.

7. Livermore DM Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012;27:128-142.

8. Nordmann P Trends in beta-lactam resistance among Enterobacteriaceae. Clin Infect Dis 1998;27(Suppl 1):S100-S106.

9. Alcantar-Curiel D, Tinoco JC, Gayosso C, Carlos A, Daza C, Perez-Prado MC, Salcido L, Santos JI, Alpuche-Aranda CM. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 2004;38:1067-1074.

10. Garza-González E, Mendoza Ibarra SI, Llaca-Díaz JM, Gonzalez GM Molecular characterization and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico. J Med Microbiol 2011;60:84-90.

11. Garza-Ramos U, Martínez-Romero E, Silva-Sánchez J SHV-type extended-spectrum beta-lactamase (ESBL) are encoded in related plasmids from enterobacteria clinical isolates from Mexico. Salud Publica Mex 2007;49:415-421.

12. Miranda G, Castro N, Leaños B, Valenzuela A, Garza-Ramos U, Rojas T, Solórzano F, Chihu L, Silva J Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum beta-lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004;42:30-35.

13. Morfín-Otero R, Mendoza-Olazarán S, Silva-Sánchez J, Rodríguez-Noriega E, Laca-Díaz J, Tinoco-Carrillo P, Petersen L, López P, Reyna-Flores F, Alcantar-Curiel D, Garza-Ramos U, Garza-González E Characterization of Enterobacteriaceae isolates obtained from a tertiary care hospital in Mexico, which produces extended-spectrum β-lactamase. Microb Drug Resist 2013;19:378-383.

14. Mosqueda-Gómez JL, Montaño-Loza A, Trolón AL, Cervantes C, Bobadilla-del-Valle JM, Silva-Sánchez J, Garza-Ramos U, Villasís-Keever A, Galindo-Fraga A, Palacios GM, Ponce-de-Leon A, Sifuentes-Osornio J. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. A case-control study. Int J Infect Dis 2008;12:653-659.

15. Muro S, Garza-González E, Camacho-Ortiz A, Gonzalez GM, Llaca-Díaz JM, Bosques F, Rositas F Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Chemotherapy 2012;58:217-224.

16. Silva J, Gatica R, Aguilar C, Becerra Z, Garza-Ramos U, Velázquez M, Miranda G, Leaños B, Solórzano F, Echániz G Outbreak of infection with extended-spectrum betalactamase-producing Klebsiella pneumoniae in a Mexican hospital. J Clin Microbiol 2001;39:3193-3196.

17. Silva-Sánchez J, Garza-Ramos JU, Reyna-Flores F, Sánchez-Perez A, Rojas-Moreno T, Andrade-Almaraz V, Pastrana J, Castro-Romero JI, Vinuesa P, Barrios H, Cervantes C Extended-spectrum β-lactamase-producing Enterobacteriaceae causing nosocomial infections in Mexico. A retrospective and multicenter study. Arch Med Res 2011;42:156-162.

18. Espinoza de los Monteros LE, Silva-Sánchez J, Jiménez LV, Rojas T, Garza-Ramos U, Valverde VOutbreak of infection by extended-spectrum beta-lactamase SHV-5-producing Serratia marcescens in a Mexican hospital. J Chemother 2008;20:586-592.

19. CLSI (2011) Performance standards for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute.

20. Pfaller MA, Segreti J Overview of the epidemiological profile and laboratory detection of extended-spectrum betalactamases. Clin Infect Dis 2006;42(Suppl 4):S153-S163.

21. Gouby A, Neuwirth C, Bourg G, Bouziges N, Carles-Nurit MJ, Despaux E, Ramuz M Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994;32:301-305.

22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.

23. Mathew A, Harris AM, Marshall MJ, Ross GW The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol 1975;88:169-178.

24. Bush K, Singer SB Effective cooling allows sonication to be used for liberation of beta-lactamases from gram negative bacteria. J Antimicrob Chemother 1989;24:82-84.

25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory.

26. Miller JH (1992) Experiments in molecular genetics. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.

27. Siu LK, Lu PL, Hsueh PR, Lin FM, Chang SC, Luh KT, Ho M, Lee CY Bacteremia due to extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol 1999;37:4020-4027.

28. Babini GS, Livermore DM Are SHV beta-lactamases universal in Klebsiella pneumoniae? Antimicrob Agents Chemother 2000;44:2230.

29. Gutmann L, Ferré B, Goldstein FW, Rizk N, Pinto-Schuster E, Acar JF, Collatz E SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother 1989;33:951-956.

30. Bradford PA Automated thermal cycling is superior to traditional methods for nucleotide sequencing of bla(SHV) genes. Antimicrob Agents Chemother 1999;43:2960-2963.

31. Billot-Klein D, Gutmann L, Colatz E Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob Agents Chemother 1990;34:2439-2441.

32. Coque TM, Baquero F, Canton R Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13:pii19044.

33. Wirtz VJ, Dreser A, Gonzales R Trends in antibiotic utilization in eight Latin American countries, 1997-2007. Rev Panam Salud Publica 2010;27:219-225.

34. Iosifidis E, Farmaki E, Nedelkopoulou N, Tsivitanidou M, Kaperoni M, Pentsoglou V, Pournaras S, Athanasiou-Metaxa M, Roilides E Outbreak of bloodstream infections because of Serratia marcescens in a pediatric department. Am J Infect Control 2012;40:11-15.

35. O'Brien TF, Pla MP, Mayer KH, Kishi H, Gilleece E, Syvanen M, Hopkins JD Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid. Science 1985;230:87-88.